Who Should Consider Alternatives Anyone with personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2 should avoid all GLP-1 and related medications including Retatrutide
There is no clinical-trial program combining cagrilintide with retatrutide, and no data on such a pairing
Post-prandial levels of insulin and GLP-1 normalized with nutrient administration into the stomach rather than the gastric bypass route, suggesting that altered nutrient delivery to the intestines contributes to dumping syndrome ( To better understand the timing of hormone secretion in relation to hypoglycemia in dumping syndrome, glucose, insulin, GLP-1, and norepinephrine levels were measured following a meal in patients with dumping syndrome, and compared to levels and timing of peak in control patients
In a study of more than 1.6 million patients with T2D and no prior diagnosis of OACs, patients treated with GLP-1s had a significantly lower risk for 10 of the listed cancers
Notably, 65.3% of participants taking retatrutide 12 mg achieved a BMI 22 at Week 80
In clinical data, the outcomes were stark